| | Category | Subcategory | Total studied cohort (62,681) | Patients without stroke (59,912) | Patients with stroke (2,769) | value | | Number (%) | Number (%) | Number (%) |
| Age (years)
| 25–44 | 11,197 (17.9) | 11,135 (18.58) | 62 (2.24) | <0.0001 | | 45–64 | 31,914 (50.9) | 30,996 (51.74) | 918 (33.15) | <0.0001 | | ≥65 | 19,570 (31.2) | 17,781 (29.68) | 1,789 (64.61) | <0.0001 |
| | Gender | Male | 32,868 (52.4) | 30,997 (51.74) | 1,871 (67.57) | <0.0001 | | Female | 29,813 (47.6) | 28,915 (48.26) | 898 (32.43) | <0.0001 |
| Marital Status
| Single | 2,150 (3.43) | 2,113 (3.53) | 37 (1.34) | <0.0001 | | Married | 57,325 (91.46) | 54,748 (91.38) | 2,577 (93.07) | 0.002 | | Divorced | 641 (1.02) | 606 (1.01) | 35 (1.26) | 0.197 | | Widow | 2,565 (4.09) | 2,445 (4.08) | 120 (4.33) | 0.512 |
| | Family history of DM | Positive | 25,187 (40.18) | 24,370 (40.68) | 817 (29.51) | <0.0001 |
| | Smoking | Ever smoked | 4,286 (6.84) | 3,983 (6.65) | 303 (10.94) | <0.0001 |
| | BMI (kg/m2) | ≤25 | 10,743 (17.14) | 10,137 (16.92) | 606 (21.89) | <0.0001 | | 25–29.9 | 20,855 (33.27) | 19,746 (32.96) | 1,109 (40.05) | <0.0001 | | ≥30 | 31,083 (49.59) | 30,029 (50.12) | 1,054 (38.06) | <0.0001 |
| Diabetes type
| Type 1 | 2,604 (4.55) | 2,568 (98.62) | 36 (1.31) | <0.0001 | | Type 2 | 54,669 (95.45) | 51,953 (95.03) | 2,716 (98.69) | <0.0001 |
| | DM duration (years) | <5 | 8,101 (12.92) | 7,951 (13.27) | 150 (5.42) | <0.0001 | | 5–10 | 18,844 (30.06) | 18,341 (30.61) | 503 (18.16) | <0.0001 | | >10 | 35,736 (57.01) | 33,620 (56.12) | 2,116 (76.42) | <0.0001 |
| | Neuropathy | Yes | 11,153 (17.79) | 10,263 (17.13) | 890 (32.14) | <0.0001 |
| | Retinopathy | Yes | 11,262 (17.97) | 10,523 (17.56) | 739 (26.69) | <0.0001 |
| | Nephropathy | Yes | 6,252 (9.97) | 5,711 (9.53) | 541 (19.54) | <0.0001 |
| | Vasculopathy | Total | 10,384 (16.57) | 7,615 (12.71) | 2,769 (100) | <0.0001 | | CAD | 8,020 (12.79) | 7,282 (12.15) | 738 (26.65) | <0.0001 | | PVD | 197 (0.31) | 170 (0.28) | 27 (0.98) | <0.0001 |
| | Hypertension | Yes | 29,399 (46.90) | 27,045 (45.14) | 2,354 (85.01) | <0.0001 |
| | Hyperlipidemia | Yes | 22,701 (36.22) | 21,344 (35.63) | 1,357 (49.01) | <0.0001 |
| | Treatment | Oral agents alone | 46,834 (74.72) | 45,001 (75.11) | 1,833 (66.20) | <0.0001 | | Insulin ± oral agents | 23,005 (36.70) | 21,704 (36.23) | 1,301 (46.98) | <0.0001 |
|
|
